SPONDYLOARTHRITIS
Clinical trials for SPONDYLOARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new SPONDYLOARTHRITIS trials appear
Sign up with your email to follow new studies for SPONDYLOARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Biosimilar switch safe and effective for inflammatory diseases
Disease control CompletedThis study checked whether patients with rheumatoid arthritis, spondyloarthritis, Crohn's disease, or uveitis could safely switch from the original drug Remicade to its lower-cost biosimilar Inflectra. Researchers followed 262 adults at one hospital who had already received at le…
Matched conditions: SPONDYLOARTHRITIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 04:00 UTC
-
Smartwatch study shows promise for arthritis patients
Disease control CompletedThis study tested whether using connected fitness trackers (like smartwatches) could encourage people with spondyloarthritis to be more physically active and reduce disease flares. 108 adults with stable spondyloarthritis participated. The goal was to see if the devices work bett…
Matched conditions: SPONDYLOARTHRITIS
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New pill shows promise for back arthritis sufferers
Disease control CompletedThis study tested a daily pill called upadacitinib in 734 adults with axial spondyloarthritis, a type of arthritis that causes back pain and stiffness. The drug aims to reduce symptoms like pain and inflammation. Participants received either the drug or a placebo, and researchers…
Matched conditions: SPONDYLOARTHRITIS
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Arthritis patients may ditch IV drips for home shots
Disease control CompletedThis study tested whether people with rheumatoid, psoriatic, or spine arthritis could safely switch from receiving infliximab through an IV at the hospital to giving themselves a simple injection at home every two weeks. 22 adults who were already stable on IV infliximab were off…
Matched conditions: SPONDYLOARTHRITIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Shiatsu shows promise for fatigue in spinal arthritis
Symptom relief CompletedThis study tested whether shiatsu, a Japanese finger-pressure therapy, can reduce fatigue in people with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine). 72 adults aged 18 to 70 took part. Researchers measured fatigue using a standard questionnaire …
Matched conditions: SPONDYLOARTHRITIS
Phase: NA • Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
Simple exercises boost balance in seniors with back pain
Symptom relief CompletedThis study looked at whether five simple physiotherapy exercises could help improve balance and reaction speed in older adults (ages 65-95) with arthritis of the spine. 60 people took part, with half doing a three-week exercise program and the other half not. The results showed t…
Matched conditions: SPONDYLOARTHRITIS
Phase: NA • Sponsor: Anna Olczak • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
Researchers hunt for clues to predict arthritis progression
Knowledge-focused CompletedThis study looked at 70 people with spondyloarthritis, a type of inflammatory arthritis affecting the spine and joints, to find immune markers that might predict how the disease will progress and how well treatments work. Participants provided blood samples and had their disease …
Matched conditions: SPONDYLOARTHRITIS
Sponsor: Hospital for Special Surgery, New York • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC